BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19915340)

  • 1. [Biology and treatment of indolent lymphomas: follicular lymphoma and marginal zone B-cell lymphoma].
    Nishikori M
    Rinsho Ketsueki; 2009 Oct; 50(10):1332-41. PubMed ID: 19915340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment strategy for indolent B-cell lymphoma].
    Tobinai K
    Rinsho Ketsueki; 2001 Apr; 42(4):288-92. PubMed ID: 11400299
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic advances for indolent lymphomas].
    Ogura M
    Nihon Rinsho; 2000 Mar; 58(3):682-94. PubMed ID: 10741147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Up-to-date treatment of follicular lymphomas].
    Dreyling M; Buske C; Hiddemann W
    Dtsch Med Wochenschr; 2005 Sep; 130(38):2149-54. PubMed ID: 16172957
    [No Abstract]   [Full Text] [Related]  

  • 5. Indolent lymphomas: current and emerging treatment approaches.
    Maloney D; Kahl BS; Dreyling M
    Clin Adv Hematol Oncol; 2006 Sep; 4(9 Suppl 20):1-10; quiz 11-2. PubMed ID: 17139243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolent lymphomas of mature B lymphocytes.
    Kurtin PJ
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):769-90. PubMed ID: 19577169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCCN: Non-Hodgkin's lymphoma.
    Zelenetz AD; Hoppe RT;
    Cancer Control; 2001; 8(6 Suppl 2):102-13. PubMed ID: 11760551
    [No Abstract]   [Full Text] [Related]  

  • 8. [Malignant lymphoma in adults].
    Fridrik MA
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2109-14. PubMed ID: 18985565
    [No Abstract]   [Full Text] [Related]  

  • 9. NCCN preliminary non-Hodgkin's lymphoma practice guidelines.
    Oncology (Williston Park); 1997 Nov; 11(11A):281-46. PubMed ID: 9430195
    [No Abstract]   [Full Text] [Related]  

  • 10. Transformation of marginal zone lymphoma (and association with other lymphomas).
    Casulo C; Friedberg J
    Best Pract Res Clin Haematol; 2017; 30(1-2):131-138. PubMed ID: 28288708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Follicular lymphoma].
    Illés A; Krenács L; Borbényi Z
    Orv Hetil; 2003 Nov; 144(46):2253-61. PubMed ID: 14702920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant lymphoma. Physiopathology and treatment. 2. Lymphoma of low grade malignancy].
    Kobayashi Y
    Nihon Naika Gakkai Zasshi; 2008 Jul; 97(7):1581-7. PubMed ID: 18720599
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrafollicular neoplasia/"in situ" lymphoma: a proposal for morphology and immunodiagnostic classification.
    Carbone A; Gloghini A
    Am J Hematol; 2011 Aug; 86(8):633-9. PubMed ID: 21674580
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.
    Hamadani M; Benson DM; Lin TS; Porcu P; Blum KA; Devine SM
    Eur J Haematol; 2008 Dec; 81(6):425-31. PubMed ID: 18774954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma].
    Ogura M
    Rinsho Ketsueki; 2008 Oct; 49(10):1434-50. PubMed ID: 18833928
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary cutaneous B-cell lymphoma: subtypes, treatment and outcome of 10 cases.
    Onsun N; Su O; Kural YB; Erdemoglu Y; Buyukbabani N; Demirkesen C; Aydin Y
    Acta Derm Venereol; 2011 Jun; 91(4):476-8. PubMed ID: 21537819
    [No Abstract]   [Full Text] [Related]  

  • 17. Current management of follicular lymphomas.
    Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Unterhalt M
    Br J Haematol; 2007 Jan; 136(2):191-202. PubMed ID: 17073892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells.
    Bu X; Zheng Z; Wang C; Yu Y
    Pathol Res Pract; 2007; 203(3):163-7. PubMed ID: 17307308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic lymphoproliferative disorders].
    Salles G
    Rev Prat; 2002 May; 52(9):966-71. PubMed ID: 12063762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma.
    de Vos S; Goy A; Dakhil SR; Saleh MN; McLaughlin P; Belt R; Flowers CR; Knapp M; Hart L; Patel-Donnelly D; Glenn M; Gregory SA; Holladay C; Zhang T; Boral AL
    J Clin Oncol; 2009 Oct; 27(30):5023-30. PubMed ID: 19770386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.